Dr. Cornel Stanciu of Dartmouth Health discusses his research on kratom, an herbal supplement that is widely available but carries addiction risks for some users.

While the FDA has classified synthetic kratom as a public health threat and dozens of states have enacted regulations or bans ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

Background: Cardiovascular disease caused by atherosclerosis is responsible for 18 million deaths annually, highlighting a significant need for new medical therapies, especially for patients who are ...

Living with chronic pain can feel overwhelming, especially when conventional treatments fall short. You've probably heard ...

Takeda Pharmaceutical Co. Ltd. has synthesized heterocyclic compounds acting as orexin OX2 receptor (OX2R; HCRTR2) agonists reported to be useful for the treatment of narcolepsy, among others.

DelveInsight's Alcohol Use Disorder Market Insights report includes a comprehensive understanding of current treatment practices, alcohol use disorder emerging drugs, market share of individual ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

New Jersey, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Pinnacle Treatment Centers, a leader in providing evidence-based care for ...

Dear Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties : As we prepare to end 2025, we would like to provide you with this open letter summarizing our ...

For adults with type 2 diabetes and/or overweight/obesity and high triglycerides, GLP-1RAs are not associated with pancreatitis.

By Dennis Thompson HealthDay ReporterTHURSDAY, Nov. 20, 2025 (HealthDay News) — The opioid addiction medication buprenorphine ...